Sunday, October 11, 2026

Julie Hollar and Jim Naureckas

3 POSTS 0 COMMENTS
ulie Hollar is senior analyst for FAIR's Election Focus 2020 project. She was Extra!'s managing editor from 2008 to 2014. Jim Naureckas is the editor of FAIR.org, and has edited FAIR's print publication Extra! since 1990. He is the co-author of The Way Things Aren’t: Rush Limbaugh’s Reign of Error, and co-editor of The FAIR Reader. He was an investigative reporter for In These Times and managing editor of the Washington Report on the Hemisphere. Born in Libertyville, Illinois, he has a poli sci degree from Stanford. Since 1997 he has been married to Janine Jackson, FAIR’s program director.

POPULAR

A view of Old Sana'a, Yemen. Photo: Ferdinand Reus / CC BY-SA 2.0, via Wikimedia Commons

Corporate Media don’t understand the Houthis, and Don’t Want to, Either

A media critique of how Western outlets cover Yemen's Houthi movement, which has governed the capital Sanaa since 2014.
A natural gas flare at a petroleum well site in New Mexico. Photo: James St. John / CC BY 2.0, via Wikimedia Commons

EPA plans to rescind methane Super Emitter Program, citing estimated $45 billion in savings

Administrator Lee Zeldin announced the plan to oil and gas executives in Santa Fe, and the agency's release gives no method for its savings figure.
U.S. currency. Photo: Public domain, via Wikimedia Commons

Companies that saw federal cases dropped gave or pledged $210.5 million to Trump-aligned super...

Public Citizen's tracker lists more than 200 corporations that benefited from canceled enforcement, and the group says its database is not comprehensive.
Early voters wait inside a polling place in Florida. Photo: Alex Johnson / CC BY-SA 2.0, via Wikimedia Commons

Lawsuits ask courts to bar armed federal agents from polling places before the midterms

New Mexico has already barred them by state law, and the Department of Homeland Security says it has no plans for operations at polls.
Vials of ketamine. Photo: Psychonaught (CC0), via Wikimedia Commons

Ketamine: What to know about the drug at the center of the Cornell case

Ketamine is a powerful drug with promise for treating depression in small doses. Recreational use is risky, especially combined with alcohol.